Product Reports Resources Pricing Login Book a demo
Bent Jakobsen
Person profile

Bent Jakobsen

Founded
SynaptixBio, Accession Therapeutics, Adaptimmune +1 more
Education
Aarhus University, Aarhus University

Companies founded

SynaptixBio
Board Member · Founder · 2021 – present
$16.9M valuation (2022)
→
Accession Therapeutics
CEO · Founder · 2020 – present
$241.6M valuation (2025)
→
Adaptimmune
Co-fournder · CSO · Founder · 2008 – 2018
$7.4M valuation (2026)Unicorn
→
Immunocore
CSO · Founder · 2008 – 2020
$1.6B valuation (2026)Unicorn
→

Currently

Active roles, board seats and partnerships.

Engimmune Therapeutics
Chairman of the Board · 2022 – present
$97.9M valuation (2022)
→
Etcembly
Board Member · 2021 – present
$3.5M valuation (2025)
Nextera AS
Board Member · 2021 – present

Education

Aarhus University
Msc · Molecular Biology · 1980 – 1984
Aarhus University
PhD · Biochemistry, Molecular Biology · 1980 – 1987
← All people